menu
    • menu

    Company profile for Abpro

    NEW Drugs in Dev: 4
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Abpro Corporation is a clinical-stage biotechnology company, that engages in developing next-generation antibody therapies, for patients with severe disease in multiple areas, including immuno-oncology/cancer, infectious disease, ophthalmology, and autoimmunity. Its lead product candidates include ABP-100 for the treatment of breast, gastric, and endometrial cancers; ABP-201 for the treatment of vascular diseases of the eye;...
    Abpro Corporation is a clinical-stage biotechnology company, that engages in developing next-generation antibody therapies, for patients with severe disease in multiple areas, including immuno-oncology/cancer, infectious disease, ophthalmology, and autoimmunity. Its lead product candidates include ABP-100 for the treatment of breast, gastric, and endometrial cancers; ABP-201 for the treatment of vascular diseases of the eye; ABP-150 for gastric cancer; and ABP-300 for COVID-19. Abpro Corporation has partnership agreements with Essex Bio-Investment Ltd., AbMed Corporation, MedImmune Ltd., and Luye Pharma Group Ltd., Memorial Sloan Ketterin

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AbproUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    68 Cummings Park Drive, Woburn, MA 01801
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://abpro.co/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    Asia Pharma Expo

    Not Confirmed

    envelop Contact Supplier

    Asia Pharma Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Celltrion Spotlights Abpro's ABP-102 at 44th JPM Conference
    Celltrion Spotlights Abpro's ABP-102 at 44th JPM Conference

    15 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/15/3219396/0/en/Abpro-s-Lead-Program-ABP-102-Featured-in-Celltrion-Presentation-at-the-44th-Annual-J-P-Morgan-Healthcare-Conference.html

    GLOBENEWSWIRE
    15 Jan 2026
    Share Share
    Abpro & Celltrion Gain FDA Clearance For Cancer Antibody ABP-102
    Abpro & Celltrion Gain FDA Clearance For Cancer Antibody ABP-102

    06 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/06/3213468/0/en/Abpro-and-Celltrion-Inc-Announce-U-S-FDA-IND-Clearance-for-Lead-Multispecific-Antibody-Cancer-Candidate-ABP-102-CT-P72.html

    GLOBENEWSWIRE
    06 Jan 2026
    Share Share
    Abpro Holdings Submits IND For Phase 1 Trial Of T Cell Engager
    Abpro Holdings Submits IND For Phase 1 Trial Of T Cell Engager

    15 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/15/3205290/0/en/Abpro-Holdings-Announces-Submission-of-an-IND-Application-to-Initiate-a-Phase-1-Clinical-Trial-of-T-cell-engager-ABP-102-CT-P72-for-HER2-positive-Cancers.html

    GLOBENEWSWIRE
    15 Dec 2025
    Share Share
    Abpro Extends Nasdaq Listing For Compliance And Strategy Pursuit
    Abpro Extends Nasdaq Listing For Compliance And Strategy Pursuit

    09 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/09/3202228/0/en/Abpro-Granted-Nasdaq-Listing-Extension-to-Pursue-Compliance-and-Strategic-Objectives.html

    GLOBENEWSWIRE
    09 Dec 2025
    Share Share
    Abpro, Celltrion To Showcase Next-Gen HER2×CD3 T-Cell Engager
    Abpro, Celltrion To Showcase Next-Gen HER2×CD3 T-Cell Engager

    04 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/04/3180471/0/en/Abpro-and-Celltrion-to-Present-Preclinical-Data-for-CT-P72-ABP-102-at-SITC-2025-Highlighting-a-Next-Generation-HER2-CD3-T-Cell-Engager.html

    GLOBENEWSWIRE
    04 Nov 2025
    Share Share
    Abpro, Celltrion reveal data for ABP-102/CT-P72 at AACR 2025
    Abpro, Celltrion reveal data for ABP-102/CT-P72 at AACR 2025

    27 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/27/3068834/0/en/Abpro-and-Celltrion-Unveil-Preclinical-Data-for-ABP-102-CT-P72-at-AACR-2025-Showcasing-Potential-Best-in-Class-HER2-x-CD3-T-Cell-Engager.html

    GLOBENEWSWIRE
    27 Apr 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search